Halozyme Therapeutics Inc (HALO)
38.03
-0.36
(-0.94%)
USD |
NASDAQ |
Apr 17, 16:00
38.03
0.00 (0.00%)
After-Hours: 20:00
Halozyme Therapeutics Price: 38.03 for April 17, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 16, 2024 | 38.35 | 38.81 | 38.08 | 38.39 | 550699.0 |
| Apr 15, 2024 | 38.89 | 39.27 | 38.48 | 38.72 | 843658.0 |
| Apr 12, 2024 | 39.00 | 39.28 | 38.53 | 38.61 | 780317.0 |
| Apr 11, 2024 | 39.49 | 39.79 | 39.16 | 39.32 | 733624.0 |
| Apr 10, 2024 | 39.25 | 39.84 | 38.90 | 39.28 | 1.882M |
| Apr 09, 2024 | 40.07 | 40.71 | 39.52 | 40.13 | 719105.0 |
| Apr 08, 2024 | 41.09 | 41.36 | 39.85 | 39.91 | 1.164M |
| Apr 05, 2024 | 39.80 | 41.50 | 39.80 | 41.07 | 1.328M |
| Apr 04, 2024 | 40.40 | 40.63 | 39.44 | 39.73 | 1.040M |
| Apr 03, 2024 | 40.30 | 40.67 | 39.99 | 40.23 | 689359.0 |
| Apr 02, 2024 | 40.81 | 40.94 | 39.70 | 40.43 | 943225.0 |
| Apr 01, 2024 | 40.68 | 41.60 | 40.38 | 41.32 | 813128.0 |
| Mar 28, 2024 | 40.82 | 40.99 | 40.44 | 40.68 | 707395.0 |
| Mar 27, 2024 | 40.51 | 40.94 | 40.31 | 40.73 | 601140.0 |
| Mar 26, 2024 | 40.57 | 40.58 | 39.94 | 40.08 | 625814.0 |
| Mar 25, 2024 | 40.00 | 40.61 | 39.90 | 40.42 | 672983.0 |
| Mar 22, 2024 | 40.30 | 41.03 | 40.04 | 40.08 | 794808.0 |
| Mar 21, 2024 | 40.69 | 42.30 | 40.12 | 40.22 | 928092.0 |
| Mar 20, 2024 | 40.52 | 40.58 | 39.69 | 40.38 | 837236.0 |
| Mar 19, 2024 | 40.46 | 41.32 | 40.46 | 40.81 | 847975.0 |
| Mar 18, 2024 | 40.93 | 40.96 | 40.32 | 40.37 | 1.046M |
| Mar 15, 2024 | 40.56 | 41.48 | 40.56 | 40.86 | 1.827M |
| Mar 14, 2024 | 41.08 | 41.30 | 39.94 | 40.79 | 1.498M |
| Mar 13, 2024 | 42.13 | 42.64 | 41.14 | 41.35 | 1.181M |
| Mar 12, 2024 | 41.55 | 42.12 | 41.28 | 41.95 | 964210.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
13.90
Minimum
Mar 18 2020
59.44
Maximum
Dec 02 2022
34.98
Average
38.12
Median
Price Benchmarks
| Johnson & Johnson | 144.51 |
| Globus Medical Inc | 51.21 |
| Denali Therapeutics Inc | 16.82 |
| AIM ImmunoTech Inc | 0.4909 |
| Protalix BioTherapeutics Inc | 1.14 |
Price Related Metrics
| PE Ratio | 18.02 |
| PS Ratio | 6.152 |
| PEG Ratio | 0.3960 |
| Price to Book Value | 57.55 |
| Price to Free Cash Flow | 13.67 |
| Earnings Yield | 5.55% |
| Market Cap | 4.823B |
| PEGY Ratio | 0.3960 |
| Operating PE Ratio | 15.11 |
| Normalized PE Ratio | 19.68 |